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Available online 13 October 2017Background: Few patients have access to cognitive behaviour therapy for psychosis (CBTp) even though at least
16 sessions of CBTp is recommended in treatment guidelines. Briefer CBTp could improve access as the same
number of therapists could see more patients. In addition, focusing on single psychotic symptoms, such as
auditory hallucinations (‘voices’), rather than on psychosis more broadly, may yield greater beneﬁts.
Method: This pilot RCT recruited 28 participants (with a range of diagnoses) from NHS mental health services
who were distressed by hearing voices. The study compared an 8-session guided self-help CBT intervention for
distressing voices with a wait-list control. Data were collected at baseline and at 12 weeks with post-therapy as-
sessments conducted blind to allocation. Voice-impact was the pre-determined primary outcome. Secondary
outcomes were depression, anxiety, wellbeing and recovery. Mechanism measures were self-esteem, beliefs
about self, beliefs about voices and voice-relating.
Results: Recruitment and retention was feasible with low study (3.6%) and therapy (14.3%) dropout. There were
large, statistically signiﬁcant between-group effects on the primary outcome of voice-impact (d=1.78; 95% CIs:
0.86–2.70), which exceeded the minimum clinically important difference. Large, statistically signiﬁcant effects
were found on a number of secondary and mechanism measures.
Conclusions: Large effects on the pre-determined primary outcome of voice-impact are encouraging, and criteria
for progressing to a deﬁnitive trial are met. Signiﬁcant between-group effects onmeasures of self-esteem, nega-
tive beliefs about self and beliefs about voice omnipotence are consistentwith these beingmechanisms of change
and this requires testing in a future trial.rsity of Susse
kate.cavanag
uk (A.-M. Jon
. This is an o© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
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Self-help1. Introduction
The National Institute for Health and Care Excellence (NICE, 2014)
recommends everyone with a psychosis diagnosis should be offered at
least 16 sessions of cognitive behaviour therapy (CBT). In practice, the
dissemination of CBT for psychosis (CBTp) is extremely poor. Fewer
than 10% of patients are offered CBTp in the UK (Schizophrenia
Commission, 2012) – with lack of resources the most frequently cited
barrier to implementation (Ince et al., 2015). This is a global issue,
with half of people with psychosis worldwide not receiving anyx, Falmer, Brighton
h@sussex.ac.uk
es),
pen access article underintervention (World Health Organisation (WHO), 2014). Because
funding for mental health services is unlikely to increase in the coming
years, we must consider ways to increase access that use only the
resources currently available.
The Improving Access to Psychological Therapies (IAPT) initiative in
England has substantially improved access to CBT for people with de-
pression and anxiety by offering briefer, guided, self-help forms of CBT
within a stepped care approach (Clark, 2011). This could be a way for-
ward for CBTp too: The results from recent meta-analyses show that
brief CBTp (b16 sessions) leads to signiﬁcant beneﬁts (Hazell et al.,
2016b; Naeem et al., 2016). Concurrently, this ﬁeld is moving towards
a symptom-speciﬁc approach (Birchwood and Trower, 2006), whereby
CBTp targets a speciﬁc symptom, such as delusions or distressing voices,
rather than psychosismore broadly. By combining these two areas of re-
search, we have developed a brief, guided self-help CBT intervention for
distressing voices (CBTv). In line with the CBTv model (Birchwood and
Chadwick, 1997), the aim of this intervention is to reduce the negative
impact of voices, rather than reduce or change voice characteristics.the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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trolled trial (RCT) of guided self-help CBTv compared to a wait-list con-
trol for mental health service users distressed by voices, irrespective of
diagnosis (Hazell et al., 2016a). This study aims to: (1) determine
whether ﬁndings justify a deﬁnitive trial of the intervention, (2) estab-
lish the effect size on voice-impact (primary outcome) for use in future
study sample calculations, and (3) assess the feasibility and acceptabil-
ity of the intervention and study design.
2. Method
2.1. Trial design
This trial is a pragmatic, single-blind, external pilot RCT comparing
guided self-help CBTv to a wait-list control using 1:1 allocation ratio
(Fig. 1). Both groups received usual mental health care throughout theFig. 1. Trial CONSORT diagram. Note: TAU= treatment asstudy. The study protocol was published before recruitment ended
(Hazell et al., 2016a).
2.2. Participants
Participants were recruited between September 2015 and January
2016. All participants were accessing NHS mental health services in
the South of England. We recruited 28 participants (14 per arm – in
linewith pilot RCT guidelines (Julious, 2005))whomet the following in-
clusion criteria: (1) aged 18 years or older; (2) currently distressed by
hearing voices, quantiﬁed by a score of at least 3 on either item 5
(‘how much do the voices interfere with your daily activities?’), 6
(‘how distressing are the voices that you hear?’), or 7 (‘how bad do
the voices make you feel about yourself?’) on the Hamilton Program
for Schizophrenic Voices Questionnaire (HPSVQ) (Van Lieshout and
Goldberg, 2007); (3) heard voices for the previous 12 months;usual; CBTv = cognitive behaviour therapy for voices.
443C.M. Hazell et al. / Schizophrenia Research 195 (2018) 441–447(4) currently receiving care from NHS mental health services; (5) not
currently receiving psychological therapy and not having plans to do
so; (6) able to read and write in English.
Exclusion criteria were: (1) primary diagnosis of substance misuse;
(2) an organic illness causing voices. With the exception of these
criteria, participants were not excluded on the basis of diagnosis. This
decision was ﬁrstly a response to a number of studies that have found
non-signiﬁcant differences in the experience of hearing voices between
those with and without a psychosis diagnosis (e.g. Hepworth et al.,
2013; Toh et al., 2015); and secondly a reaction to calls for interventions
targeting distressing voices that can be offered transdiagnostically
(Thomas et al., 2014).
Diagnosis was conﬁrmed by the most recent psychiatrist clinic let-
ter; all diagnoses were made in line with ICD-10 criteria (World
Health Organisation (WHO), 1992). Two participants (7.1%) (one per
arm)were not taking psychiatric medication at the time of the baseline
assessment; both had previously taken antipsychotic medication; 21
(75.0%) participants were prescribed at least one antipsychotic medica-
tion. See Table 1 and Fig. 1 for further recruitment and participant
information.
2.3. Intervention and control arms
2.3.1. Guided self-help CBTv
Participants randomised to the intervention arm were offered up to
eight, hour-long sessions of guided self-help CBTv, over a maximum of
12 weeks. The intervention was based on the ‘Overcoming Distressing
Voices’ CBT self-help book (Hayward et al., 2012), and an accompanying
workbook created for this trial. All participants received a therapy pack
that included the self-help book,workbook, a carers' information leaﬂet,
and information about a local Hearing Voices Network group. The ther-
apy protocol and pack were developed in partnership with people who
hear voices.
Each session was linked to a speciﬁc chapter within the Overcoming
Distressing Voices book (Hayward et al., 2012), and the intervention
was divided into ﬁve modules: (1) Coping – exploring ways to manage
voices; (2) Me – targeting negative beliefs about the self; (3) My Voices
- targeting unhelpful beliefs about voices; (4) My Relationships –Table 1
Baseline participant demographics. Note: TAU = treatment as usual; employment status ‘Othe
schizophrenia, paranoid schizophrenia, schizoaffective disorder, psychosis not otherwise speci
chotic features and bipolar disorder; diagnosis ‘Other’ includes posttraumatic stress disorder (P
Variable Guided s
Age M(SD) 39.07(10
Gender n(%) Male 4(28.60)
Female 9(64.30)
Other 1(7.10)
Employment status n(%) Employed 3(21.40)
Unemployed 10(71.40
Other 1(7.10)
Marital status n(%) Single 6(42.90)
Married/civil partnership 1(7.10)
Cohabiting 2(14.30)
Separated/divorced 5(35.70)
Widowed 0(0.00)
Country of birth n(%) England 13(92.90
Other 1(7.10)
Ethnicity n(%) White (British) 13(92.90
White (Other) 1(7.10)
Level of education n(%) Left school before 16 7(50.00)
Left school at 16 2(14.30)
Left school at 17/18 3(21.40)
Completed/completing college course 1(7.10)
Completed/completing university course 1(7.10)
Age of voice onsetM(SD) 28.50(14
Diagnosis n(%) Psychosis spectrum diagnosis 5(35.71)
Borderline personality disorder 5(35.71)
Mood disorder 1(7.15)
Other 3(21.43)improving assertiveness in difﬁcult relationships; and (5) Looking to
the Future – making plans to continue the use of new skills. Modules
2, 3 and 4 were each offered over two sessions (six sessions in total),
and modules 1 and 5 were each one session long.
All of the trial therapists were clinical psychologists with extensive
CBTp experience; additional training on guided self-help CBTvwas pro-
vided by authors. All of the trial therapists were offered monthly group
supervision.
2.3.2. Wait list control
All participants (both arms) received their usual treatment through-
out the study. The control group was assigned to a wait list for CBTv
which ended when they had completed the 12 week (T1) assessment.
2.4. Outcome measures
All outcome measures were collected at baseline (T0), and post-
intervention (12 weeks post-randomisation, T1). Assessments were
conducted at the participants' local mental health facility; where partic-
ipants had mobility issues, home visits were offered. The voice-impact
subscale on the Hamilton Program for Schizophrenia Voices Question-
naire (HPSVQ) (Van Lieshout andGoldberg, 2007)was the primary out-
come (Hazell et al., 2016a). This subscale, conﬁrmed through factor
analysis, has 4 items (Kim et al., 2010). Scores on the self-report
HPSVQ (Van Lieshout and Goldberg, 2007) correlate highly (all r N
0.8) (Kim et al., 2010) with scores on the widely used, clinician-
administered PSYRATS auditory hallucination (AH) scale (Haddock
et al., 1999). The secondary outcome measures were: (1) the Choice of
Outcome In Cbt for psychosEs (CHOICE) questionnaire severity subscale
(Greenwood et al., 2010): a measure of service-user deﬁned recovery,
including two items where participants identify their personal goals;
(2) the Hospital Anxiety and Depression Scale (HADS) (Zigmond and
Snaith, 1983); (3) the Short Warwick-Edinburgh Mental Well-being
Scale (SWEMBS) (Tennant et al., 2007); (4) the Rosenberg Self-
Esteem Scale (RSES) (Rosenberg, 1965).
The measures of proposed mechanisms of action were: (1) the Brief
Core Schema Scale (BCSS) self-scale (Fowler et al., 2006): a measure of
participants' positive and negative beliefs about themselves; (2) ther’ includes student, homemaker, retired and carer; psychosis spectrum disorder includes
ﬁed and ﬁrst episode psychosis; mood disorder includes depression, depression with psy-
TSD) and dissociative identity disorder (DID).
elf-help CBTv + TAU (n= 14) Wait list + TAU (n= 14) Total (n= 28)
.16) 45.93(13.49) 42.50(12.23)
7(50.00) 11(39.30)
7(50.00) 16(57.10)
0(0.00) 1(3.60)
4(28.60) 7(25.00)
) 5(35.70) 15(53.60)
4(28.60) 5(17.90)
7(50.00) 13(46.40)
3(21.40) 4(14.30)
0(0.00) 2(7.10)
2(14.30) 7(25.00)
2(14.30) 2(7.10)
) 10(71.40) 23(82.10)
4(28.60) 5(17.90)
) 12(85.70) 25(89.30)
2(14.30) 3(10.70)
4(28.60) 11(39.30)
3(21.40) 5(17.90)
4(28.60) 7(25.00)
1(7.10) 2(7.10)
2(14.30) 3(10.70)
.22) 23.71(17.76) 26.11(15.97)
8(57.14) 13(46.43)
3(21.43) 8(28.57)
3(21.43) 4(14.29)
0(0.00) 3(10.71)
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(Birtchnell et al., 2013): a measure of social relating patterns; (3) the
Voice and You (VAY) (Hayward et al., 2008): ameasure of voice relating
patterns; (4) the Beliefs about Voices Questionnaire – revised (BAVQ-R)
(Chadwick et al., 2000): ameasure of participants' positive and negative
beliefs about their voices; (5) HPSVQ phenomenology subscale (Van
Lieshout and Goldberg, 2007): a measure of voice phenomenology. Par-
ticipants in the intervention arm were also asked to complete a patient
experience questionnaire based on the IAPT service experience ques-
tionnaire (Clarke, 2011).
2.5. Randomisation and masking
Participants completed the T0 assessments and were then
randomised to either receive guided self-help CBTv or join the wait-
list by an independent statistician blind to participant details. Partici-
pants were randomised using a 1:1 ratio with random permuted block
randomisation using block sizes of two, four, and six. The T1 assess-
mentswere completed by a research assistantwhowas blind to the par-
ticipants' group allocation. Blinding was broken once part-way through
a T1 assessment.
2.6. Statistical analyses
All of the analyses were conducted in linewith the trial data analysis
plan (Hazell et al., 2016a) using STATA version 13. The recruitment and
consent rates have been reported in line with the Consolidated Stan-
dards of Reporting Trials (CONSORT) guidelines.
All of the standardised effect sizes were coded so that a positive ef-
fect size favours the intervention group over the control group. The be-
tween group effect sizes are interpreted in line with Cohen's (Cohen,
1960) criteria (i.e. small ≥ 0.2, medium ≥ 0.5, and a large effect ≥ 0.8).
The minimum clinically important difference (MCID) on the primary
outcome was 2 points difference. Missing data on individual outcome
items were treated as missing completely at random. Missing items
were imputed using simple mean imputation.
2.7. Ethics and research governance
Ethical approval was granted by the North West – Lancaster Re-
search Ethics Committee (REC) (ref: 15/NW/0575). The trial was spon-
sored by the University of Sussex, and registered with the International
Standard Randomised Controlled Trial Registry (ISRCTN77762753). In
line with Medical Research Council (MRC) (Medical Research Council
(MRC), 1998) the study was monitored by a Trial Steering Committee
with an independent Chair, independent expert and lived experience
member.
2.8. Adverse events
Seven adverse events were reported during the course of the study:
ﬁve were hospital admissions (two for physical health, and three for
mental health), one report of suicidal intent, and one disengagement
from services. None of the adverse events were deemed to be related
to the study. All participants in the intervention armwhowere admitted
to hospital chose to continue with the intervention when they were
discharged.
3. Results
3.1. Recruitment, retention and adherence
Of the 39 study referrals, 28 (71.8%) consented and were
randomised (Table 1). Only one participant (3.6%) did not provide
data at both time points (Fig. 1). Participants were deemed to have
been exposed to the intervention if they attended at least four out ofthe eight intervention sessions. Two participants randomised to the in-
tervention arm did not begin therapy (Fig. 1). Of the 12 participants
who began the intervention, 1 participant attended four sessions
(8.3%), 3 participants (25.0%) attended seven sessions, and 8 partici-
pants (66.7%) attended all eight sessions.
3.2. Primary outcome
There was a large, statistically signiﬁcant between-group effect in
favour of the intervention group (d = 1.78, 95% CI 0.86, 2.70) on the
HPSVQ voice-impact subscale (Table 2). The difference between pre-
post change scores (4.05) exceeds the MCID of 2.
3.3. Secondary outcomes
All between-group effect sizes for secondary outcomes favoured
guided self-help CBTv over the wait-list condition. There were large,
statistically signiﬁcant between-group effects (d N 0.8) on service-user
deﬁned recovery (CHOICE), anxiety (HADS anxiety), and wellbeing
(SWEMBS) (Table 2). Effects on depression (HADS) were small and
non-signiﬁcant (d= 0.27).
3.4. Mechanism outcomes
All between-group effect sizes for mechanism outcomes favoured
guided self-help CBTv over thewait-list condition. Therewere large, sta-
tistically signiﬁcant between-group effects (d N 0.8) for negative beliefs
about self (BCSS), beliefs about voice omnipotence (BAVQ-R) and self-
esteem (RSES) (Table 2). Effects on remaining mechanism measures
were small to medium and non-signiﬁcant (Table 2).
3.5. Patient experience
Of the 12 intervention participants, 11 (91.7%) reported they were
‘very satisﬁed’with the therapy, and ‘very satisﬁed’with their therapist.
One participant (8.3%) reported they were ‘dissatisﬁed’ with the thera-
py and ‘neutral’ about their therapist. When asked about the overall
experience of the therapy, 9 participants reported they were ‘very satis-
ﬁed’ (75.0%), 2 participants were ‘satisﬁed’ (16.7%), and 1 participant
was ‘neutral’ (8.3%).
Table 3 shows the results of the patient experience questionnaire.
Most participants reported beneﬁt across all of the items. The areas
where participants most frequently reported no improvement were
the management and reduction of medication (‘Not at all/Somewhat’:
n = 5; 41.7%), and physical health (‘Not at all/Somewhat’: n = 6;
50.0%). Conversely, the areas where participants most frequently re-
ported largest improvements were their mental health and wellbeing
(‘Very much so/Quite a lot’: n = 6; 50.0%), and their ability to engage
in meaningful activities (‘Very much so’: n= 7; 58.3%). All participants
(100%) said theywould recommend guided self-help CBTv to a friend or
family member who was hearing distressing voices.
4. Discussion
4.1. Summary of results
This study aimed to: (1) determine whether ﬁndings justiﬁed a de-
ﬁnitive trial of the guided self-help CBTv intervention, (2) establish
the effect size on voice-impact (primary outcome) for use in future
study sample calculations, and (3) assess the feasibility and acceptabil-
ity of the intervention and study design.
We found a large, statistically signiﬁcant between-group effect on
the pre-determined primary outcome of voice-impact, as well as on a
range of secondary outcomes (anxiety, wellbeing, and recovery), and
mechanisms (self-esteem, beliefs about self, and beliefs about voices).
Furthermore, the small therapy (14.3%) and study (3.6%) attrition
Table 2
Primary and secondary outcomes at T0 (baseline) and T1 (12weeks post randomisation).Note: HPSVQ=Hamilton Program for Schizophrenic Voices Questionnaire; CHOICE= Choice of
Outcome In Cbt for psychosEs; HADS = Hospital Anxiety and Depression Scale; SWEMBS= Short Warwick-Edinburgh Mental Well-being Scale; RSES = Rosenberg Self-Esteem Scale;
BCSS = Brief Core Schema Scale; PROQ3 = Persons Relating to Others Questionnaire short version; VAY = Voice and You; BAVQ-R = Beliefs about Voices Questionnaire – the revised
edition; * = p b 0.05 and 95% CIs do not cross zero; Β=unstandardised effect; d= standardised effect; 95% CI for d calculated using the standard deviation for Cohen's d (Cohen, 1960).
T0 T1 Β (SE; 95% CI) d (95% CI)
Guided self-help CBTv
+ TAU (n= 14)
Wait list control group
+ TAU (n= 14)
Guided self-help CBTv
+ TAU (n= 13)
Wait list control group
+ TAU (n= 14)
M(SD) M(SD) M(SD) M(SD)
Primary outcome
HPSVQ (voice-impact) 13.14(1.96) 11.21(2.08) 9.31(4.27) 11.43(2.77) −3.93
(1.31;−6.65,−1.22)
1.78*
(0.86, 2.70)
Secondary outcomes
CHOICE 3.37(1.80) 3.52(1.68) 5.68(1.78) 3.29(1.97) 2.39
(0.59; 1.17, 3.61)
1.40*
(0.54, 2.26)
CHOICE (goals only) 5.07(4.70) 4.93(3.85) 12.38(4.13) 5.71(4.76) 6.47
(1.65; 3.07, 9.88)
1.54*
(0.66, 2.42)
HADS depression 10.42(3.70) 11.58(3.05) 10.32(2.85) 11.92(2.60) −0.92
(0.89;−2.77, 0.92)
0.27
(−0.50, 1.04)
HADS anxiety 12.17(2.96) 11.08(3.26) 9.06(2.34) 11.58(2.84) −2.91
(0.90;−4.77,−1.05)
0.94*
(0.13, 1.75)
SWEMBS 17.71(4.36) 18.36(4.07) 21.69(5.01) 17.93(5.50) 3.97
(1.69; 0.47, 7.46)
0.95*
(0.14, 1.76)
HPSVQ phenomenology 14.14(2.68) 14.93(2.73) 12.85(2.73) 14.21(3.09) −0.87
(0.92;−2.78, 1.04)
0.32
(−0.45, 1.09)
HPSVQ total 27.29(3.93) 26.14(3.66) 22.15(6.50) 25.64(4.89) −4.51
(1.83;−8.29,−0.73)
1.20*
(0.36, 2.04)
Mechanism outcomes
RSES 10.07(6.23) 10.79(4.42) 15.07(5.37) 10.71(5.37) 4.41
(1.75; 0.79, 8.03)
0.83*
(0.03, 1.63)
BCSS (negative self) 12.50(5.64) 9.36(5.00) 5.15(5.76) 9.64(5.06) −6.21
(1.68;−9.67,−2.75)
1.13*
(0.30, 1.96)
BCSS (positive self) 4.14(5.16) 6.79(5.71) 8.08(4.99) 7.36(6.55) 2.41
(1.72;−1.14, 5.97)
0.44
(−0.34, 1.22)
PROQ3 60.64(17.19) 48.86(12.56) 49.38(15.96) 51.14(15.63) −9.27
(4.85;−19.27, 0.74)
0.58
(−0.21, 1.37)
VAY voice dominance 18.14(2.74) 14.50(6.20) 17.23(3.35) 15.50(4.31) −0.46
(1.00;−2.53, 1.61)
0.09
(−0.68, 0.86)
VAY voice intrusiveness 9.36(4.38) 9.86(3.88) 10.69(3.79) 10.57(3.23) 0.27
(1.28;−2.38, 2.92)
0.07
(−0.70, 0.84)
VAY hearer dependence 9.93(4.81) 5.50(3.65) 5.31(3.97) 6.00(4.40) −2.65
(1.63;−6.02, 0.71)
0.56
(−0.22, 1.34)
VAY hearer distance 14.64(3.61) 14.43(4.62) 13.92(3.69) 14.71(3.91) −1.07
(1.46;−4.08, 1.94)
0.26
(−0.51, 1.03)
BAVQ malevolence 13.29(4.39) 10.43(5.32) 10.62(4.54) 11.14(4.64) −2.24
(1.31;−4.95, 0.46)
0.45
(−0.33, 1.23)
BAVQ benevolence 1.64(2.37) 2.86(3.74) 0.62(1.50) 1.71(3.22) −0.58
(0.82;−2.26, 1.11)
0.18
(−0.59, 0.95)
BAVQ omnipotence 13.57(3.72) 11.86(3.30) 10.15(4.18) 12.43(3.61) −3.11
(1.34;−5.87;−0.36)
0.88*
(0.07, 1.69)
BAVQ resistance (feelings) 10.50(1.79) 8.50(3.25) 8.62(3.40) 9.14(2.25) −1.08
(1.16;−3.48, 1.32)
0.39
(−0.39, 1.17)
BAVQ resistance (behaviour) 10.14(4.15) 11.50(3.35) 11.69(2.25) 12.64(2.59) −0.66
(0.87;−2.47, 1.14)
0.18
(−0.59, 0.95)
BAVQ engagement (feelings) 0.64(1.34) 1.57(2.41) 0.15(0.38) 0.79(1.72) −0.31
(0.42;−1.17, 0.55)
0.16
(−0.61, 0.93)
BAVQ engagement (behaviour) 1.86(2.57) 2.38(1.85) 1.23(1.42) 1.64(1.95) −0.49
(0.68;−1.90, 0.92)
0.22
(−0.55, 0.99)
445C.M. Hazell et al. / Schizophrenia Research 195 (2018) 441–447rates suggest the studydesign and interventionwere acceptable– this is
supported by the positive patient experience questionnaire ﬁndings.
However, this was a pilot RCT not designed to draw deﬁnitive conclu-
sions and ﬁndings should be considered in this light.
4.2. Primary outcome
The large effect on voice-impact is in contrast with the majority of
CBTp trials which have found minimal effects on measures of voice-
related impact (Haddock et al., 2009; Morrison et al., 2014; Valmaggia
et al., 2005); despite the cognitive model of voices identifying this as
the goal of CBT (Chadwick and Birchwood, 1994). It is possible that
symptom-focused CBTp (as in the present study) leads to larger effectson voice-impact. However, these previous studies were in psychosis
samples, and differences in effect size may be attributable to the
transdiagnostic sample in the current study. Further research is needed
to establish whether diagnosis is a moderator of CBTp outcomes.4.3. Secondary outcomes
Large, statistically signiﬁcant between-group effects on anxiety,
wellbeing, and recovery suggest beneﬁts of the intervention could ex-
tend beyond the primary outcome of voice-impact. Effects on depres-
sion were small and non-signiﬁcant but in favour of the intervention
group.
Table 3
Results from the patient experience questionnaire. Note: N/A = not applicable.
Not at all/somewhat
n(%)
Moderately so
n(%)
Very much so/quite a lot
n(%)
N/A
n(%)
The therapy I received has
Improved your mental health and wellbeing 2(16.7) 4(33.3) 6(50.0) 0(0)
Reduced the need for support from your GP 2(16.7) 1(8.3) 6(50.0) 3(25.0)
Helped you to better manage or reduce your medication 5(41.7) 1(8.3) 5(41.7) 1(8.3)
Helped to promote improvements in your physical health 6(50.0) 3(25.0) 3(25.0) 0(0)
Helped you to engage with community activities 3(25.0) 6(50.0) 3(25.0) 0(0)
Helped you to improve relationships with others 2(16.7) 4(33.3) 6(50.0) 0(0)
Helped to improve the amount of sick time that you take from work 2(16.7) 1(8.3) 0(0) 9(75.0)
Helped you to improve your ability to engage in meaningful activities 1(8.3) 4(33.3) 7(58.3) 0(0)
446 C.M. Hazell et al. / Schizophrenia Research 195 (2018) 441–447The between-group effect on the measure of voices characteristics
(e.g. frequency, duration, volume) was small. This ﬁnding is in line
with the aim of CBTv, whereby the goal of therapy is not to reduce
voices, but to reduce thenegative impact associatedwith the experience
(Chadwick and Birchwood, 1994).
4.4. Mechanism measures
There were large, statistically signiﬁcant effects on self-esteem, neg-
ative beliefs about self and voice omnipotence. Believing a voice is om-
nipotent is strongly associated with greater levels of voice distress
(Hacker et al., 2008), it is therefore plausible that changes in these
proposed mechanisms may be in part mediating effects on clinical out-
comes. This hypothesis should be explored in future research.
Effects on other mechanism measures - positive beliefs about self,
voice malevolence and relating measures consistently favoured the in-
tervention group, but were in the small or medium range, and non-
signiﬁcant, which could indicate that guided self-help CBTv has limited
impact on these variables. In particular, the modest, non-signiﬁcant ef-
fects on the relating subscales could be because two sessions with a re-
lating focus is insufﬁcient to promote substantial changes in negative
relating; indeed, Relating Therapy is typically delivered over 16 sessions
(Hayward et al., 2017). The role these proposed mechanisms of change
play in mediating effects on voice-impact now requires testing within a
deﬁnitive trial of guided self-help CBTv.
4.5. Recruitment, retention and acceptability
Study recruitment, retention, therapy adherence rates, and patient
experience results suggest the study design and intervention were ac-
ceptable. The study dropout rates were smaller than those reported in
meta-analyses of CBTp. For example, our study dropout rate was 3.6%,
compared to 14.5% (Wykes et al., 2007) and 5.5% (Hazell et al.,
2016b). It is also encouraging that if participants completed theﬁrst ses-
sion of therapy then they all continued with therapy to the point of ex-
posure (4 sessions).
4.6. Limitations
As the present study is a pilot RCT, the sample size is intentionally
small, which explains the wide conﬁdence intervals. Findings should
therefore be interpreted in light of this. Also, the use of a wait-list con-
trol groupmeanswewere unable to control for non-speciﬁc therapeutic
effects. A deﬁnitive trial, with an active control group, that has sufﬁcient
statistical power is now needed to fully test the effectiveness of this
intervention.
Recruitment for this study was transdiagnostic. Due to the small
sample size we were unable to investigate whether psychiatric diagno-
sis moderated outcomes. The cognitive model of voices can be applied
to those who hear voices in the context of psychosis and non-
psychosis diagnoses (Waters et al., 2012). However the experience, im-
pact and treatment implications of hearing voices in people with non-psychosis diagnoses requires further research attention (Waters et al.,
2014). A larger trial will allow us to determine whether outcomes are
moderated by diagnosis.
The primary outcomemeasure (HPSVQ) has not, as yet, beenwidely
used in clinical trials. Scores on the self-report HPSVQ correlate highly
(all r N 0.8) with scores on the well-established clinician-administered
PSYRATS-AH (Kim et al., 2010). However, the psychometric study by
Kim et al. (2010) was in a Korean sample and further validation of the
HPSVQ is now required.
The long-term aim of guided self-help CBTv is to help increase access
to CBT for people distressed byhearing voices. Our intervention requires
50% of the contact time (8 sessions) recommended by NICE (16+ ses-
sions), meaning twice as many patients could be seen without increas-
ing resources. Moreover, given the lack of trained CBTp therapists (Ince
et al., 2015; Mueser and Noordsy, 2005), frontline staff (i.e. mental
health nurses) could be trained to deliver the intervention in order to
further increase access. CBTp may be effective when delivered by non-
accredited therapists (Turkington et al., 2014; Waller et al., 2013). Fur-
ther research is needed to identify whether guided self-help CBTv
would be acceptable, feasible, and effective when delivered by frontline
practitioners.4.7. Clinical implications
Because the present study is a pilot RCT, we do not recommend that
guided self-help CBTv be offered in routine practice at this time. Howev-
er, ﬁndings are promising and support the continued investigation of
guided self-help CBTv within a deﬁnitive trial.4.8. Research implications
There are a number of potential future research ideas. Our current
research priority is to explore the effects of guided self-help CBTv deliv-
ered by therapists and frontline mental health practitioners as part of a
deﬁnitive trial; with mediation analysis to test potential mechanisms,
and moderation analysis to explore the impact of psychiatric diagnosis
on outcomes.4.9. Conclusions
Guided self-help CBTv was associated with a large and statistically
signiﬁcant between-group effect size on voice-impact. Low study and
intervention drop-out rates, with high participant satisfaction, suggest
our intervention is acceptable. Guided self-help CBTv warrants further
investigation.Conﬂicts of interest
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